Research Article
ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
Figure 2
The level of ENO1 in plasma of PDAC patients, corresponding to clinical stages and prognosis. (a) Scatter plot demonstrated the ENO1 concentrations in plasma of PDAC patients () and normal controls (). ENO1 was detected with amplified luminescent proximity homogeneous assay (AlphaLISA) method. (b) Scatter plot represented the ENO1 concentrations in plasma of PDAC patients with different clinical stages (stage I: ; stage II: ; stage III: ; stage IV: ). , .
(a) |
(b) |